Related Experiment Video
Updated: Jun 18, 2026

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
Is exhaled nitric oxide a useful adjunctive test for assessing asthma?
Jonathan A Bernstein1, Ben Davis, María J Alvarez-Puebla
1University of Cincinnati College of Medicine, Department of Internal Medicine, Division of Immunology/Allergy Section, Ohio, USA.
Fractionated exhaled nitric oxide (FeNO) can help assess asthma, particularly in mild, untreated cases. However, its utility is limited by asthma severity and treatment variations in broader patient groups.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Clinical Diagnostics
Background:
- Asthma patient characterization relies on clinical and physiological markers.
- Key parameters include the Asthma Control Test (ACT), forced expiratory volume in 1 second (FEV1), and fractionated exhaled nitric oxide (FeNO).
Purpose of the Study:
- To evaluate the clinical utility of ACT, FEV1, and FeNO in characterizing asthma patients.
- To compare these parameters between distinct patient populations in the US and Spain.
Main Methods:
- Two independent cross-sectional studies enrolled 100 (US) and 109 (Spain) adult asthma patients.
- Asthma diagnosis was physician-confirmed with bronchodilator response or airway hyperresponsiveness.
- Patients with COPD or current smoking were excluded; no restrictions on asthma severity or treatment.
Main Results:
- Significant differences observed in age, %FEV1, FeNO, inhaled corticosteroid (ICS) use, and atopy between US and Spain sites.
- Milder asthma and lower ICS use noted in the Spain cohort.
- FeNO levels decreased with improved asthma control categories at both sites, with lower mean FeNO in the US.
- A significant negative correlation between ACT and FeNO was found in Spain patients not using ICS.
Conclusions:
- FeNO shows promise as an adjunctive tool for assessing asthma, especially in mild, ICS-naïve patients.
- The heterogeneity of asthma severity and treatment regimens complicates the correlation of ACT with FeNO across diverse patient populations.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
